These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36214033)

  • 21. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
    Kant A; Jansen J; van Balveren L; van Hunsel F
    Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.
    Chen M; Yuan Y; Zhou Y; Deng Z; Zhao J; Feng F; Zou H; Sun C
    Infect Dis Poverty; 2021 Jul; 10(1):94. PubMed ID: 34225791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
    PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccination for patients with epilepsy: A Chinese expert consensus.
    Liu X; Wang Q; Ren L; Fang X; He Z; Ding J; Wang K; Xu H; Zhang H; Song Y; Lu Q; Sun M; Han X; Cao L; Lin W; Li X; Zhang Q; Ding Y; Wang F; Wang T; Wang J; Liu X; Wu Y; Chen Y; Feng Z; Wang S; Wang X; Guan Y; Xie X; Huang H; Zhang M; Wang X; Hong Z; Jiang W; Han Y; Deng Y; Zhao J; Liao J; Wang Y; Lian Y
    Epilepsy Behav; 2023 Oct; 147():109387. PubMed ID: 37625346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of adverse effects following immunisation degree after the administration COVID-19 vaccine of different platforms.
    Bermawi B; Donastin A; Sari NDK; Kurniasari DW; Adriansyah AA; Ferdiansyah MA; Rofananda IF; Surya PA
    Med J Malaysia; 2024 Mar; 79(2):124-127. PubMed ID: 38553914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis.
    Fan J; Zhu L; Wu X; Luo C; Huang A; Wang W
    Front Public Health; 2023; 11():1072883. PubMed ID: 37397712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine Safety: Assessing the Prevalence and Severity of Adverse Events Following COVID-19 Vaccination amongst Healthcare Workers in Tertiary Health Facilities in Nigeria.
    Azees AS; Fasiku MM; Isa A; Ezenwoko AZ; Ahmed A; Temitayo-Oboh AO; Utulu R; Adeniyi MA; Musa A; Alo C; Ibrahim UM; Imhonopi GB; Adesoye OO; Okeke IM; John GT; Ayinla AY
    Niger Postgrad Med J; 2024 Jan; 31(1):1-7. PubMed ID: 38321791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.
    von Wrede R; Pukropski J; Moskau-Hartmann S; Surges R; Baumgartner T
    Epilepsy Behav; 2021 Sep; 122():108160. PubMed ID: 34166950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of coronavirus disease 2019 vaccination on seizures in patients with epilepsy.
    Fang X; Qiao S; Zhang R; Yang T; Wang Z; Kong Q; Sun M; Geng J; Fang C; Chen Y; Sun Y; Zhang D; Qu L; Shang W; Wang J; Liu X
    Chin Med J (Engl); 2023 Mar; 136(5):571-577. PubMed ID: 36848187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: A clinical observation in China.
    Huang A; Lu Y; Ji J; Yao Y; Guan S; Chen Z; Yu L
    Hum Vaccin Immunother; 2022 Nov; 18(6):2141519. PubMed ID: 36412219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of routine childhood vaccine coadministration versus separate vaccination.
    Bauwens J; de Lusignan S; Weldesselassie YG; Sherlock J; Künzli N; Bonhoeffer J
    BMJ Glob Health; 2022 Sep; 7(9):. PubMed ID: 36162867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: A single-centre experience in Malaysia.
    Gan LL; Zahidah AR; Hazirah T; Nabilah HK; Aisyah Z; Amin INM; Ng DCE
    Med J Malaysia; 2022 May; 77(3):300-305. PubMed ID: 35638485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and prevalence of COVID-19 vaccination in patients with focal epilepsy following resection surgery.
    Yang Y; Lv J; He C; Shen C; Xu S; Guo Y; Ding Y; Zheng Z; Zhu J; Wang S; Ding M; Wang S
    Epilepsy Behav; 2023 Aug; 145():109344. PubMed ID: 37459719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes following COVID-19 vaccination and associated factors among healthcare professionals in Oromia region, Ethiopia.
    Terefa DR; Shama AT; Tekle E
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167901. PubMed ID: 36703523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
    Duijster JW; Lieber T; Pacelli S; Van Balveren L; Ruijs LS; Raethke M; Kant A; Van Hunsel F
    Front Immunol; 2023; 14():1078736. PubMed ID: 36793715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria.
    Shragai T; Adegoke OJ; Ikwe H; Sorungbe T; Haruna A; Williams I; Okonkwo R; Onu K; Asekun A; Gberikon M; Iwara E; Abimiku A; Rufai A; Okposen B; Gidudu J; Lam E; Bolu O
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.